Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Clin Infect Dis ; 74(10): 1812-1820, 2022 05 30.
Article in English | MEDLINE | ID: mdl-34409431

ABSTRACT

BACKGROUND: The impact of remdesivir (RDV) on mortality rates in coronavirus disease 2019 (COVID-19) is controversial, and the mortality effect in subgroups of baseline disease severity has been incompletely explored. The purpose of this study was to assess the association of RDV with mortality rates in patients with COVID-19. METHODS: In this retrospective cohort study we compared persons receiving RDV with those receiving best supportive care (BSC). Patients hospitalized between 28 February and 28 May 2020 with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection were included with the development of COVID-19 pneumonia on chest radiography and hypoxia requiring supplemental oxygen or oxygen saturation ≤94% with room air. The primary outcome was overall survival, assessed with time-dependent Cox proportional hazards regression and multivariable adjustment, including calendar time, baseline patient characteristics, corticosteroid use, and random effects for hospital. RESULTS: A total of 1138 patients were enrolled, including 286 who received RDV and 852 treated with BSC, 400 of whom received hydroxychloroquine. Corticosteroids were used in 20.4% of the cohort (12.6% in RDV and 23% in BSC). Comparing persons receiving RDV with those receiving BSC, the hazard ratio (95% confidence interval) for death was 0.46 (.31-.69) in the univariate model (P < .001) and 0.60 (.40-.90) in the risk-adjusted model (P = .01). In the subgroup of persons with baseline use of low-flow oxygen, the hazard ratio (95% confidence interval) for death in RDV compared with BSC was 0.63 (.39-1.00; P = .049). CONCLUSION: Treatment with RDV was associated with lower mortality rates than BSC. These findings remain the same in the subgroup with baseline use of low-flow oxygen.


Subject(s)
COVID-19 Drug Treatment , Adenosine Monophosphate/analogs & derivatives , Alanine/analogs & derivatives , Humans , Oxygen , Retrospective Studies , SARS-CoV-2
2.
Am J Infect Control ; 44(11): 1219-1223, 2016 11 01.
Article in English | MEDLINE | ID: mdl-27424303

ABSTRACT

BACKGROUND: Over 90% of annual deaths caused by Clostridium difficile infection (CDI) occur in persons aged ≥65 years. However, no large-scale studies have been conducted to investigate predictors of CDI-related mortality among older adults. METHODS: This case-control study included 540 CDI patients aged ≥60 years admitted to a tertiary care hospital in Detroit, Michigan, between January 2005 and December 2012. Cases were CDI patients who died within 30 days of CDI date. Controls were CDI patients who survived >30 days after CDI date. Cases were matched to controls on a 1:3 ratio based on age and hospital acquisition of CDI. RESULTS: One-hundred and thirty cases (25%) were compared with 405 controls (75%). Independent predictors of CDI-related mortality included admission from another acute hospital (odds ratio [OR], 8.25; P = .001) or a long-term care facility (OR, 13.12; P = .012), McCabe score ≥2 (OR, 12.19; P < .001), and high serum creatinine (≥1.7 mg/dL) (OR, 3.43; P = .021). The regression model was adjusted for the confounding effect of limited activity of daily living score, total number of antibiotic days prior to CDI, ileus on abdominal radiograph, low albumin (≤2.5 g/dL), elevated white blood cell count (>15 × 1,000/mm3), and admission to intensive care unit because of CDI. CONCLUSIONS: Predictors of CDI-related mortality reported in this study could be applied to the development of a bedside scoring system for older adults with CDI.


Subject(s)
Clostridioides difficile/isolation & purification , Clostridium Infections/mortality , Decision Support Techniques , Aged , Aged, 80 and over , Case-Control Studies , Clostridium Infections/microbiology , Female , Humans , Male , Michigan , Middle Aged , Retrospective Studies , Survival Analysis , Tertiary Care Centers
3.
Am J Infect Control ; 43(9): 983-6, 2015 09 01.
Article in English | MEDLINE | ID: mdl-26088770

ABSTRACT

BACKGROUND: Correlations between symptom documentation in medical records and patient self-report (SR) vary depending on the condition studied. Patient symptoms are particularly important in urinary tract infection (UTI) diagnosis, and this correlation for UTI symptoms is currently unknown. METHODS: This is a cross-sectional survey study in hospitalized patients with Escherichia coli bacteriuria. Patients were interviewed within 24 hours of diagnosis for the SR of UTI symptoms. We reviewed medical records for UTI symptoms documented by admitting or treating inpatient physicians (IPs), nurses (RNs), and emergency physicians (EPs). The level of agreement between groups was assessed using Cohen κ coefficient. RESULTS: Out of 43 patients, 34 (79%) self-reported at least 1 of 6 primary symptoms. The most common self-reported symptoms were urinary frequency (53.5%); retention (41.9%); flank pain, suprapubic pain, and fatigue (37.2% each); and dysuria (30.2%). Correlation between SR and medical record documentation was slight to fair (κ, 0.06-0.4 between SR and IPs and 0.09-0.5 between SR and EDs). Positive agreement was highest for dysuria and frequency. CONCLUSION: Correlation between self-reported UTI symptoms and health care providers' documentation was low to fair. Because medical records are a vital source of information for clinicians and researchers and symptom assessment and documentation are vital in distinguishing UTI from asymptomatic bacteriuria, efforts must be made to improve documentation.


Subject(s)
Bacteriuria/diagnosis , Escherichia coli/isolation & purification , Urinary Tract Infections/diagnosis , Adult , Aged , Aged, 80 and over , Cross-Sectional Studies , Documentation , Female , Health Personnel , Hospitalization , Humans , Male , Medical Records , Middle Aged , Missouri , Prospective Studies , Self Report , Statistics as Topic , Surveys and Questionnaires , Urinary Tract Infections/microbiology , Young Adult
4.
Am J Infect Control ; 42(10): 1109-11, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25278404

ABSTRACT

There is potential for person-to-person transmission in Clostridium difficile outbreak settings. A limited number of studies have examined the role of hospital roommates in the development of nosocomial infections. This retrospective cohort study evaluated room cooccupancy and duration of exposure to roommates as predictors of health care-onset C difficile infection (CDI). Among roommates of patients with CDI, duration of room cooccupancy was significantly longer in those developing CDI.


Subject(s)
Clostridioides difficile/isolation & purification , Clostridium Infections/epidemiology , Clostridium Infections/transmission , Cross Infection/epidemiology , Cross Infection/transmission , Bed Occupancy/statistics & numerical data , Clostridium Infections/microbiology , Cohort Studies , Cross Infection/microbiology , Environmental Exposure , Female , Hospitals , Humans , Male , Middle Aged , Retrospective Studies
5.
Int J Infect Dis ; 17(12): e1240-2, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23891642

ABSTRACT

Mucormycosis is a rare and devastating disease. Apophysomyces trapeziformis is an environmental mold that was recently implicated in several cases of cutaneous and soft tissue mucormycosis in victims of a tornado in Joplin, Missouri. Here, we report a case of Apophysomyces trapeziformis necrotizing soft tissue infection in a resident of Joplin 10 months after the disaster and without preceding trauma. Aspects of histological and microbiological diagnosis are also reviewed.


Subject(s)
Mucorales/isolation & purification , Mucormycosis/pathology , Soft Tissue Infections/microbiology , Soft Tissue Infections/pathology , Aged , Fatal Outcome , Female , Humans , Mucorales/classification , Mucorales/genetics , Mucormycosis/diagnosis , Mucormycosis/etiology , Mucormycosis/therapy , Necrosis , Soft Tissue Infections/diagnosis , Soft Tissue Infections/etiology , Soft Tissue Infections/therapy , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...